MicroRNA-Catalyzed Cancer Therapeutics Based on DNA-Programmed Nanoparticle Complex

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Molecular Biology

Background:

• MicroRNAs (miRNAs) are promising for personalized cancer therapy but their low abundance poses challenges.
• Existing drug delivery systems struggle with efficient and targeted release mechanisms.

Purpose of the Study:

• To develop a novel microRNA-catalyzed drug release system for cancer treatment.
• To utilize miRNA-21 as a specific trigger for doxorubicin release from a gold nanoparticle-quantum dot complex.

Main Methods:

• A DNA-programmed gold nanoparticle (GNP)-quantum dot (QD) complex was designed to load doxorubicin (Dox).
• The catalytic disassembly of the GNP-QD complex by trace amounts of miRNA-21 was investigated.
• Drug release, cellular uptake, nuclear translocation, and photoluminescence activation were monitored in fixed and live cells.

Main Results:

• miRNA-21 specifically catalyzed the disassembly of Dox-loaded GNP-QDs via an entropy-driven process.
• Doxorubicin was efficiently released in cells overexpressing miRNA-21 and translocated to the nucleus.
• Quantum dot photoluminescence was activated upon catalytic disassembly, providing feedback on drug release.
• The GNP-QDs-Dox complex demonstrated enhanced drug potency compared to free doxorubicin.

Conclusions:

• The developed system offers a promising platform for microRNA-triggered, feedback-controlled cancer drug delivery.
• This approach enhances drug potency and enables accurate and effective cancer cell treatment.
• The system shows potential for personalized cancer therapy by responding to specific cancer-relevant microRNAs.